Sol H. Weiss

Sol H. Weiss
Nationality American
Occupation Lawyer
Known for Director of the Anapol Weiss law firm
Website Anapol Weiss website

Sol H. Weiss is an American personal injury lawyer and Director of the Anapol Weiss law firm based in Philadelphia. Weiss has practiced law since 1972. He has secured many notable multimillion-dollar verdicts and settlements in national mass tort and class action litigations.

Verdicts and settlements

Co-Lead Counsel in NFL Players' Injury Litigation

Weiss serves as Co-Lead Counsel in the National Football League Players’ Concussion Injury Litigation, which reached a proposed settlement of $765 million to provide medical assistance to more than 18,000 former players suffering neurological problems. The litigation is presided over by Judge Anita B. Brody in the United States District Court for the Eastern District of Pennsylvania. The pending settlement awaits approval of the court. [1] “When Weiss and others at the firm began to hear of NFL players suffering from chronic neurological damage, likely the result of repeated concussive collisions, they began to explore the possibility of suing the NFL on the premise that it had failed to protect the players' health,” the Philadelphia Inquirer reported. “Weiss said the firm consulted with neurosurgeons and scientists, reviewed the literature, and conferred with injured players.”

Regarding the case, Weiss was interviewed for the September 2013 edition of The Philadelphia Inquirer.[2] In this article he emphasized that, "helmets can't protect you from all kinds of injuries.".[2] Weiss also spoke to students at Villanova Law School after the proposed settlement was reached. “It doesn't mean the end of football,” he said. “Football will still be around, and it will be exciting. But they're going to teach kids at a young age how to tackle, or not to tackle with their head… Any sport where you can have a concussion, I think the game will be safer for all the participants.” [3]

Products Liability Litigation

Weiss served as one of seven class counsel in the national Fen-Phen lawsuits titled In re: Diet Drugs (Phentermine, Fenfluramine, Dexfenfluramine) Products Liability Litigation. Plaintiffs in the lawsuit alleged the weight loss drugs caused valvular heart disease, an association that ultimately compelled the U.S. Food and Drug Administration to order fenfluramine and dexfenfluramine off the market in 1997.[4] The lawsuit settled for $3.75 billion.[5] Weiss was then referenced in a book titled Dispensing with the Truth: The Victims, the Drug Companies, and the Dramatic Story Behind the Battle over Fen-Phen about the complexities of the diet drug litigation.[6]

Weiss also obtained a $68.5 million settlement for 168 people seriously injured by the statin drug Baycol in the multidistrict litigation (MDL) titled In re: Baycol Products Liability Litigation.[7] Plaintiffs in the action claimed Baycol, which was commonly prescribed for high blood pressure and heart disease, caused a muscle damaging disease called rhabdomyolysis, kidney failure, and other injuries.[8] Baycol was removed from the market in 2001.

Other past cases include the $17.75 million partial settlement in the Luzerne County Kids for cash litigation [9] and the New Jersey consolidated Vioxx litigation.[10] In addition to large and complex mass tort lawsuits, Weiss has litigated medical and professional malpractice, securities litigation and various product liability cases.

Honors and awards

Weiss was named 2014 Lawyer of the Year in the category of Mass Tort and Class Action Litigation by Philadelphia’s Best Lawyers. He has been named in The Best Lawyers in America every year since 2006 [11] and was featured on the cover of the 2011 edition of the publication.[12]

Weiss was named to the Suburban Life Reader's Choice Top Attorneys in 2010.[13] The listing includes the Avvo Inc. Awesome Attorneys list as well as attorneys in various practice areas who received the most votes in a readers’ poll by Suburban Life Magazine.

Weiss received the 2009 American Association for Justice (AAJ) Harry M. Philo Award Trial Lawyer of the Year Award for his work on limiting federal preemption. Weiss also received the AAJ David Shrager President’s Award in 2011 for his contribution to the Association. The award recognizes an AAJ member who has made an outstanding contribution to civil justice and who demonstrates the late Philadelphia trial lawyer’s passion for law and the trial bar.

References

  1. ↑ "Former NFL Players: League Concealed Long-Term Effect of Head Impacts" (PDF). Retrieved September 19, 2013.
  2. 1 2 Chris Mondics (September 5, 2013). "NFL settlement was a matter of time". The Philadelphia Inquirer. Retrieved September 27, 2013.
  3. ↑ Dale, Maryclaire. "Lawyer believes $765M concussion deal will succeed". Yahoo Sports. Retrieved September 19, 2013.
  4. ↑ Hitti, Miranda. "Lasting Damage From Fen-Phen Drug?". WebMD. Retrieved September 19, 2013.
  5. ↑ "Sheila Brown; et al. v. American Home Products Corporation.". Leagle. Retrieved September 19, 2013.
  6. ↑ Mundy, Alicia (2001). Dispensing with the Truth: The Victims, the Drug Companies, and the Dramatic Story Behind the Battle over Fen-Phen. St. Martin's Press.
  7. ↑ "Baycol Product Liability Litigation". US District Court District of Minnesota. Retrieved September 19, 2013.
  8. ↑ "Description of MDL No. 1431". US District Court District of Minnesota. Retrieved September 19, 2013.
  9. ↑ Michael R. Sisak (January 6, 2012). "Attorney: Proposed Mericle settlement has safeguards". Citizens Voice. Retrieved September 17, 2013.
  10. ↑ "IN RE: VIOXX : PRODUCTS LIABILITY LITIGATION" (PDF). US District Court Eastern District Of Louisiana. Retrieved September 19, 2013.
  11. ↑ "Sol Weiss of Anapol Schwartz Named 2014 Lawyer of the Year in Best Lawyers". Market Wired. Retrieved August 19, 2013.
  12. ↑ "Philadelphia Mass Tort Powerhouse Anapol Schwartz". Best Lawyers. April 23, 2011.
  13. ↑ "Reader's Choice Top Attorneys". Suburban Life Magazine. Retrieved September 18, 2013.
This article is issued from Wikipedia - version of the Thursday, February 25, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.